Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized phasE II Study for Efficacy of healThcare prOvider's REcommened Communication With Sympathy in Terminally Ill Cancer Patients Treated With Palliative Sedation

NCT04642677 is registered in ClinicalTrials.gov with Pusan National University Yangsan Hospital as lead sponsor.

NCT NCT04642677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04642677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized phasE II Study for Efficacy of healThcare prOvider's REcommened Communication With Sympathy in Terminally Ill Cancer Patients Treated With Palliative Sedation
Lead sponsor
Pusan National University Yangsan Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
November 1, 2020
Completion date
November 30, 2022
Enrollment
62 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

communication, palliative sedation